Study record

The impact of mitokine MOTS-c administration on the soleus muscle of rats subjected to a 7-day hindlimb suspension

Sidorenko DA, Lvova ID, Tyganov SA et al. · J Muscle Res Cell Motil · 2025

AnimalMOTS-c administeredEvidence tier C

What this study reported

Reported that administered MOTS-c prevented the increase in soleus muscle fatigue and the transformation of slow fibres into fast fibres during hindlimb unloading in male rats. Found that atrophy of slow fibres, but not fast fibres, was mitigated, that the decreases in Akt and GSK3β phosphorylation were prevented, that 18S and 28S rRNA remained at control levels, and that MuRF and Atrogin-1 mRNA were lower than in placebo-injected unloaded rats. Reported that decreases in several mitochondrial biogenesis markers and in ACC phosphorylation were also prevented in these rats.

Limitations

Male rats only and a single strain; group sizes not reported in the abstract; a single unloading model with surrogate molecular endpoints and no functional recovery follow-up.

Study record

Annotated fields for this study
Study modelAnimal study (in vivo)
Substance studiedMOTS-c administeredSynthetic MOTS-c was given to cells, animals or people.
Speciesrat
System studiedMale Wistar rats undergoing hindlimb unloading, with soleus muscle analysed
PopulationNot reported
DesignControlled animal experiment
Sample size as reportednot reported
Control groupplacebo-injected hindlimb-unloaded rats and non-unloaded control rats
Route (data field only)intraperitoneal
Endpoints measuredmuscle fatigue; slow-to-fast fibre transformation; fibre cross-sectional area; Akt and GSK3β phosphorylation; MuRF and Atrogin-1 mRNA; mitochondrial biogenesis markers and ACC phosphorylation
Pathways measuredAKT / mTOR / FOXO · AMPK signalling · SIRT1 / PGC-1α / biogenesis
Research areasSkeletal muscle · Mitochondrial biology
Evidence tierC — Animal in vivo
Publication typesJournal Article, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Mammalian
Sample size
Not reported
Controls
Appropriate
Outcome validity
Surrogate
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.